Literature DB >> 9502029

A prospective analysis of serum vitamin K in severely burned pediatric patients.

M E Jenkins1, M M Gottschlich, R Kopcha, J Khoury, G D Warden.   

Abstract

Patients with burn injuries exhibit multiple risk factors for the development of vitamin K deficiency, including malabsorption, limited enteral intake, antibiotic therapy, and multiple surgical procedures. A prospective evaluation of 48 children was conducted to evaluate serum vitamin K values during the first 4 postburn weeks. Serum levels were analyzed in relation to clinical course. Days of antibiotic (p < 0.02) and albumin therapy (p < 0.003), percentage body surface area excised (p < 0.006), and the administration of blood products (p < 0.05) were significantly correlated with serum vitamin K levels, and days of diarrhea approached statistical significance (p < 0.06). No relationship was found between serum values and prothrombin time, activated partial thromboplastin time, or serum albumin. Ninety-one percent of the children demonstrated serum values below expected norms. These data suggest a relationship between coagulopathy and an intact functioning gastrointestinal tract. However, the relative importance of dietary versus endogenous vitamin K produced by intestinal bacteria remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502029     DOI: 10.1097/00004630-199801000-00017

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  2 in total

1.  Protein losing enteropathy in critically ill adult patients with burns: a preliminary report.

Authors:  Balasubramanian Venkatesh; Jenny Gough; David R Ralston; Michael Muller; Stuart Pegg
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

2.  Prevalence and treatment of vitamin K deficiency in paediatric patients with recessive dystrophic epidermolysis bullosa-severe subtype.

Authors:  N Yerlett; G Petrof; K Holsgrove; A Martinez
Journal:  Skin Health Dis       Date:  2021-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.